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ABSTRACT   55 
Dietary nitrate (ܱܰଷ−) ingestion appears to enhance exercise capacity and performance in 56 
young individuals whereas inconclusive findings have been reported in older people. We 57 
conducted a double-blind, cross-over randomized clinical trial in older normal weight and 58 
overweight healthy participants testing whether beetroot juice (a rich source of ܱܰଷ−) for one 59 
week may increase nitric oxide bioavailability via the non-enzymatic pathway and enhance 1) 60 
exercise capacity during an incremental exercise test, 2) physical capability and 3) free-living 61 
physical activity.   62 
Twenty non-smoking healthy participants aged 60-75y and BMI 20.0-29.9kg/m2 were 63 
included. Pre and post supplementation resting, sub-maximal, maximal and recovery gas 64 
exchanges were measured. Physical capability was measured by hand-grip strength (HGS), 65 
time-up-and-go (TUG), repeated-chair-rising-test (RCRT), and 10m walking speed (WLS). 66 
Free-living physical activity was assessed by triaxal accelerometry. Changes in urinary and 67 
plasma ܱܰଷ−  concentrations were measured by gas chromatography mass spectrometry. 68 
Nineteen participants (M/F=9/10) completed the study.  Beetroot juice increased significantly 69 
both plasma and urinary ܱܰଷ−  concentrations (p<0.001) compared to placebo. Beetroot juice 70 
did not influence resting, sub-maximal and maximal oxygen consumption during the 71 
incremental exercise test. In addition, measures of physical capability and physical activity 72 
levels measured in free-living conditions were not modified by beetroot juice ingestion.  73 
The positive effects of beetroot juice ingestion on exercise performance seen in young 74 
individuals were not replicated in healthy, older adults. Whether aging represents a modifier 75 
of the effects of dietary ܱܰଷ−  on muscular performance is not known and mechanistic studies 76 
and larger trials are needed to test this hypothesis. 77 
 78 
Keywords: inorganic nitrate, nitric oxide, exercise, oxygen consumption, aging  79 
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1. INTRODUCTION 80 
Aging is characterized by a progressive decline in muscle mass and strength which are risk 81 
factors for physical disability[1]. Aging is also associated with modifications of 82 
mitochondrial bioenergetics with consequent effects on muscular performance[2]. Dietary 83 
nitrate ሺܱܰଷ−ሻ supplementation enhances muscular efficiency in humans[3, 4], a finding 84 
which can be explained by increased nitric oxide (NO) bioavailability and the role of NO in 85 
modulating mitochondrial coupling and bioenergetics of muscular activity[5, 6]. However, 86 
the majority of ܱܰଷ− supplementation studies have been conducted in healthy, physically 87 
active young adults[7, 8] and few studies have evaluated the effects of dietary ܱܰଷ− on 88 
physical or muscular function in older people[9-11]. Larsen et al in 2007[12] was the first to 89 
report reduced sub-maximal O2 uptake in young healthy adults after three-day oral 90 
supplementation with potassium ܱܰଷ−. Kenjale et al[10] observed delayed onset of 91 
claudication after three days of oral ܱܰଷ− supplementation in older patients with peripheral 92 
arterial disease (PAD). However, subsequent studies reported contrasting results for the 93 
effects of dietary ܱܰଷ− on exercise performance in healthy older people[9, 13] as well as in at 94 
risk populations (i.e., those with diabetes[11], heart failure[14], and chronic obstructive 95 
pulmonary disease (COPD)[15, 16]). All studies employed a double-blind randomized cross-96 
over study design and administered beetroot juice to increase ܱܰଷ− intake. However, 97 
differences in study duration, ܱܰଷ− dose or assessment of exercise capability likely 98 
contributed to the observed heterogeneous responses. For example, outcomes have included 99 
sub-maximal [12, 15, 17] or maximal oxygen (O2) uptake [18-20] assessed with incremental 100 
standardised tests [12, 15, 21] as well as time trials [22-24] or physical capability tests [9, 101 
25], all of which were performed in controlled settings. No study has investigated the effects 102 
of dietary ܱܰଷ− supplementation on free living physical activity.  103 
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We hypothesized that dietary ܱܰଷ− supplementation would increase NO bioavailability, 104 
muscular energetics and exercise performance – with significant changes expected in sub-105 
maximal, maximal and recovery O2 uptake – which may translate into beneficial effects on 106 
physical capability and free living physical activity. To test these hypotheses, we conducted a 107 
double-blind, cross-over, placebo controlled RCT in older healthy adults to investigate the 108 
effects of beetroot juice, chosen as a rich source of dietary ܱܰଷ−, on physical activity 109 
outcomes measured in research (O2 uptake during incremental cycle ergometer exercise, 110 
walking speed, time-up-and-go, repeated chair rising test and hand grip strength) and free 111 
living (accelerometry) settings.  112 
2. METHODS and MATERIALS 113 
The trial was approved by the North of Scotland Research Ethics committee (14/NS/0061) 114 
and conducted in accordance with the Declaration of Helsinki. Written informed consent was 115 
obtained from all participants. The study was a double-blind, cross-over, placebo-controlled 116 
RCT which took place between May and August 2014 across two sites (Newcastle upon Tyne 117 
and Sheffield). The duration of the each intervention was one week with a wash-out period 118 
between treatments of at least one week. This trial was registered in the International 119 
Standard Randomized Controlled Trial Number Register (ISRCTN19064955).  120 
2.1 Participants: Twenty male and female, older (60-75 y) non-obese adults (BMI range: 121 
18.5 - 29.9 kg/m2) were enrolled in the study. Participants were non-smokers and weight 122 
stable. Participants were included in the study if they did not have medical conditions or were 123 
not taking medications that might influence the study outcomes. A full list of the inclusion 124 
and exclusion criteria is provided in the Online Supplementary Material. Participants were 125 
asked to maintain their habitual diet and to avoid using chewing gum or mouth wash for at 126 
least 48 prior to the baseline visits (first and third visit) and during each of the one-week 127 
supplementation periods.  128 
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2.2 Randomization: A randomization list for each site was generated by a member of staff not 129 
involved in the study using www.sealedenvelopes.com. Each participant was randomized to 130 
the cross-over interventions (i.e., placebo  ܱܰଷ− or ܱܰଷ−  placebo). Intervention agents 131 
were dispensed at each baseline visit by two members of staff not involved in the study who 132 
had access to the stored beetroot juice and ensured the correct treatment allocation.  133 
2.3 Study Overview: A telephone screening was performed to check eligibility according to 134 
the trial inclusion and exclusion criteria. Eligible participants were invited for a further 135 
screening visit at the research facilities including measurement of BMI, resting BP and 136 
resting 12-lead electrocardiography (ECG). Participants were asked to arrive after a 12-hour 137 
overnight fast and having avoided strenuous physical activity for three days preceding the 138 
visit. If eligible, participants were randomized to a cross-over intervention and the baseline 139 
assessment continued with the measurement of body composition, collection of blood and 140 
urine samples and assessment of physical capability. Participants then rested for one hour and 141 
consumed a meal providing approximately 300kcal (CHO=85%, PRO=3%, FAT=12%). In 142 
addition, during this one-hour rest period, participants completed a series of questionnaires to 143 
assess dietary intake and physical activity. After the one-hour rest, participants were 144 
explained the exercise test while they accustomized to the ergometer. The exercise protocol is 145 
described in Figure S1 of the Online Supplementary Material. After the exercise test, 146 
instructions were provided for self-administration of the nutritional intervention (14 bottles of 147 
either ܱܰଷ− -rich or ܱܰଷ− -depleted beetroot juice; 70ml x 2/day; Beet It, James White Ltd, 148 
UK) and asked to consume one bottle of beetroot juice each morning and evening for the 149 
subsequent 7 days. The daily dose of ܱܰଷ− -rich (intervention) or ܱܰଷ− -depleted (placebo) 150 
beetroot juice contained ~12mmol and ~0.003mmol of ܱܰଷ−, respectively. Participants were 151 
provided with instructions and forms for recording wearing time of the accelerometer. This 152 
concluded Visit 1 of the trial. Participants returned to the research facilities in the morning of 153 
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day eight after they had completed a seven-day supplementation period. A detailed medical 154 
interview was conducted to ascertain any side effects experienced during the supplementation 155 
period. A resting 12-lead ECG was performed and, if normal, the study visit was completed 156 
by repeating the same assessments as performed during Visit 1. At the end of the second visit, 157 
participants were asked to resume their habitual diet and physical activity. After a wash out 158 
period of at least seven days the second phase (including Visits 3 and 4) was conducted 159 
similar to the first phase with the exception that participants crossed-over experimental arms 160 
i.e. consumed the other intervention agent.  161 
2.4 Body Composition: Bioelectrical impedance analyses (BIA) (Newcastle: TANITA 162 
418MA, Tanita Ltd, Japan; Sheffield: InBody 720 Analyser, InBody Bldg, Korea) was used 163 
to assess fat mass (FM) and fat free mass (FFM). Body weight, height and waist 164 
circumference (WC) were measured using standardized protocols.  165 
2.5 Resting Blood Pressure: Resting BP was measured in triplicate using an automated BP 166 
monitor (Omron M3, Omron Healthcare, UK) with the participant seated comfortably for 15 167 
min prior to measurement and the arm supported at the level of the heart. The recorded value 168 
was calculated as the mean of the three measurements. 169 
2.6 Physical Capability: A battery of tests (hand grip strength (HGS), timed up and go 170 
(TUG), repeated chair rise test (RCRT) and 10m walking speed (WLS)), performed in the 171 
same order at each visit, was completed at baseline and at the end visit of each phase. 172 
Triplicate measurements of HGS were performed in both arms at baseline and after 173 
intervention using a digital dynamometer (Takei 5401, Takei, Japan). The average of six 174 
measurements was calculated. To complete the TUG, participants were asked to stand up 175 
from a chair, walk three meters at a self-selected comfortable speed, cross a line on the floor, 176 
turn around, walk back, and sit down again. The RCRT was completed using a standard chair 177 
without armrests. Participants had both arms crossed against the chest, starting from the 178 
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seated position and standing up (legs straight) and sitting down (full weight on the chair) and 179 
the test calculates the time required (in seconds) to complete five repeated chair stands. For 180 
the WLS, a 10-m path with a flying start was used to avoid acceleration/deceleration effects 181 
associated with starting and stopping during this assessment. The middle 6-m of this path 182 
were used for the measurement. Patients were instructed to “walk as fast as they can” and the 183 
time (in seconds) to complete the 6-m path was recorded. 184 
2.7 Objective Measurement of Free Living Physical Activity: Participants were asked to wear 185 
a triaxial accelerometer (GT3X ActiGraph accelerometer (Pensacola, FL, USA)) above the 186 
right hip for eight consecutive days during waking hours and to remove it only for water 187 
activities (for example, swimming or bathing). Accelerometery data were collected in one-188 
minute epochs. Non-wear time was defined as 60 min or more of consecutive zero counts. 189 
One participant experienced a device malfunction and data were excluded from subsequent 190 
analysis. Counts per minute were converted into minutes of sedentary time (less than or equal 191 
to 100 counts per min), light (100-759 counts per min), moderate (1952–5724 counts per 192 
min) and vigorous-intensity (5725+ counts per min) physical activity[26]. Physical activity 193 
energy expenditure was calculated using the Freedson approach[26].   194 
2.8 Dietary and Lifestyle Questionnaires: The 9-item short form of the International Physical 195 
Activity Questionnaire (IPAQ) was used to record duration of four intensity levels of 196 
physical activity: 1) vigorous-intensity activity, 2) moderate-intensity activity, 3) walking, 197 
and 4) sitting. A combined total physical activity score was calculated and expressed in 198 
MET-minutes/week[27]. The EPIC Food Frequency Questionnaire (FFQ) was administered 199 
at baseline and the FETA software used to extract dietary (energy and nutrient) 200 
information[28].  201 
2.9 Exercise Test: An incremental exercise test was performed at baseline and at the end of 202 
each intervention period to assess pulmonary gas exchange variables at rest, during sub-203 
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maximal and maximal intensities and in the post-exercise recovery phase. Briefly, each 204 
participant underwent cardiopulmonary exercise testing on an electronically-braked cycle 205 
ergometer. The protocol included a five-minute resting phase followed by a 20 watts stepwise 206 
increase in workload every three minutes while they were invited to maintain a stable 207 
pedalling rate (60-70 rpm). After reaching 80 watts, participants were asked to exercise until 208 
exhaustion (ramp protocol: 10 watts/minute), which was followed by a five-minute passive 209 
recovery period. A graphical description of the protocol is described in Figure S1 of the 210 
Online Supplementary Material. Pulmonary gas exchange and ventilation were measured 211 
(Newcastle: MetaMax 3B, Cortex Biophysik, Leipzig, Germany; Ultima CardiO2, 212 
Medgraphics, St Paul, MN, USA). Heart rate (HR) was measured during all tests using 213 
cardio-thoracic impedance. Oxygen uptake (V̇O2), minute ventilation (V̇E), carbon dioxide 214 
excretion rate (V̇CO2), and respiratory exchange ratio (RER) were assessed. V̇O2 assessed 215 
during the last minute of the incremental exercise test was recorded as V̇O2peak. Ventilatory 216 
threshold was calculated using the V-slope method[29].  217 
2.10 Blood and Urine Collection: Fasting blood samples were collected at the beginning of 218 
each visit and centrifuged at 3,000rpm for 10 min at 4 °C within 30min of collection. 219 
Aliquots of plasma and serum were frozen and stored at –80 °C for subsequent analyses. 220 
Mid-stream urine samples were collected, in fasting conditions, into sterile containers and 221 
stored at –20 °C for subsequent analyses. 222 
2.11 Biomarker Analysis: A modified version of the gas chromatography mass spectrometry 223 
(GC-MS) method proposed by Tsikas et al[30] was used to determine ܱܰଷ−  concentrations in 224 
urine and plasma samples. The protocol and validation of the modified GC-MS method have 225 
been described elsewhere[31]. This method showed good repeatability, with coefficients of 226 
variation for replicate analyses of 7.8%, 8.6% and 12.0% for saliva, urine and plasma 227 
samples, respectively.  228 
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2.12 Sample size: The primary outcome of the study was the effect of ܱܰଷ− supplementation 229 
on VO2 consumption during sub-maximal exercise. Data on the expected effect size were 230 
obtained from a previous cross-over design study testing the effects of incremental exercise 231 
on sub-maximal and maximal O2 consumption in young adults after a six-day nitrate 232 
supplementation[32] which showed that V̇O2 during moderate exercise was 1.53±0.12 L·min-233 
1
 and 1.45±0.12 L·min-1 in the placebo and nitrate groups respectively. On this basis, 20 234 
participants were needed in a cross-over randomized trial to detect a difference of 0.08±0.12 235 
L·min-1 with a power of 0.80 and alpha of 0.05. 236 
2.13 Statistical Analyses: Repeated-Measures General Linear Models (GLM) were used to 237 
test the effect at the end of each intervention of ܱܰଷ− supplementation on measures of 238 
exercise performance and physical capability. Treatment (ܱܰଷ− vs placebo) was entered as a 239 
group factor (Tr) and the time points of the incremental exercise test as the repeated factor 240 
(Ti). Post-hoc comparison between treatment groups at each time point was performed using 241 
the Fisher LSD test. The area under the curve (AUC) for V̇O2 consumption during the 242 
incremental exercise test was calculated at baseline and end of study using the trapezoidal 243 
method. A paired t test was used to compare differences between the two interventions for the 244 
AUCs and free living physical activity outcomes. Data were presented as means ± SD or 245 
means ± 95% confidence intervals (95%CI). Analyses were conducted using Statistica 10 for 246 
Windows (StatSoft.Inc, Tulsa, OK, USA). Statistical significance was set at <0.05.         247 
3. RESULTS 248 
3.1 Participants’ characteristics, safety and Compliance with Interventions: Twenty 249 
participants were randomized to the intervention. One person developed an ischemic event 250 
during the physical exercise testing performed at the second visit and he was excluded from 251 
the study (Figure 1). The remaining 19 participants (mean age 64.7±3.0 years (range: 60 - 75 252 
years)) reported no side effects apart for the expected urine discoloration related to the 253 
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excretion of beetroot juice pigment (beeturia). All participants reported that they consumed 254 
all the intervention drinks provided and all of them completed all the measurements included 255 
in the study protocol. This included high compliance with wearing of the accelerometer (total 256 
wear time: ~7.5-8.0 days out of maximum 8 days). 257 
3.2 Dietary Intake and Self-Reported Physical Activity: Energy intake was 2728±1430 258 
kcal/day with 47±8%, 35±7% and 18±4% of energy provided by carbohydrates, fats and 259 
protein respectively. Self-reported physical activity was again not different between the 260 
placebo and the ܱܰଷ− arms as participants in both groups reported an average increase in total 261 
physical activity of approximately 300 METs/week (p=0.99) (Table 1 and Table S2 of the 262 
Online Supplementary Material). 263 
3.3 Body Composition: Mean baseline BMI was 25.6±3.4 kg/m2 with 12 participants being in 264 
the overweight category (25≤BMI<30kg/m2). Body weight was stable across the study with 265 
changes of 0.01±0.85 kg in the placebo and -0.16±0.57 kg in the intervention group (p=0.51). 266 
Similarly, no statistically significant between-treatment differences were found for FFM 267 
(0.02±1.00 kg vs 0.11±0.77 kg, p=0.65) and FM (-0.03±0.79 kg vs 0.27±0.75 kg, p=0.86) 268 
(Table 1 and Table S2 of the Online Supplementary Material). 269 
3.4 Resting Blood Pressure: Baseline resting systolic and diastolic BP ranged from 100.0 to 270 
168.0 mmHg and 62.0 to 97.0 mmHg, respectively. The decrease in systolic BP (-5.05±9.45 271 
mmHg) with ܱܰଷ− supplementation was approximately double that observed with the placebo 272 
(-2.64±9.04 mmHg) but this difference was not significant (p=0.48). Both interventions 273 
produced similar falls in diastolic BP (-3.70±5.59 vs -3.49±6.42 mmHg, p=0.90) (Table 1 274 
and Table S2 of the Online Supplementary Material). 275 
3.5 Laboratory biomarkers: Concentrations of nitrite plus nitrate ሺܱܰଶ−+ܱܰଷ−, NOx) in 276 
plasma and urine increased substantially after ܱܰଷ− supplementation by 150±77% and 277 
979±488% but not after the placebo intervention (-9±33% and -13±34%, respectively).  278 
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3.6 Gas-Exchange during Standardized Exercise: Nitrate supplementation had no significant 279 
effect on pulmonary gas exchange (O2 and CO2) measured during resting, sub-maximal, 280 
maximal and recovery phases of the incremental exercise test. O2 consumption increased 281 
linearly with the intensity of the workload and O2 consumption at exhaustion was 1.67±0.51 282 
and 1.64±0.55 L·min-1 following ܱܰଷ−and placebo interventions (p=0.86), respectively. There 283 
was a steady and comparable decline in O2 consumption during the 5-minute recovery phase 284 
with return to baseline resting values for both interventions (Figure 3A). The AUCs for O2 285 
consumption for both treatments were similar (p=0.89, data not showed). Similarly, weight-286 
adjusted O2 consumption did not significantly different between the ܱܰଷ− and placebo groups 287 
(p=0.99, Figure S2 of the Online Supplementary Material). O2 consumption at ventilatory 288 
threshold was similar for the ܱܰଷ− (0.90±0.39 L·min-1) and placebo (0.91±0.39 L*min-1) 289 
treatments (p=0.35) and no differences between the two interventions were observed for CO2 290 
production, RER, V̇E and HR (Figure 3B to 3E). Time to exhaustion was shorter following 291 
the ܱܰଷ− intervention but the difference was not significant (p=0.10, Figure 3F). The 292 
adjustment of the analyses for baseline values of gas exchanges did not modify the results 293 
(data not showed). A summary of the data for each time point is provided in Table S3 of the 294 
Online Supplementary Material. 295 
3.7 Physical Capability and Objective Assessment of Free Living Physical Activity: Physical 296 
performance was assessed using a battery of tests measuring strength, performance and 297 
balance. ܱܰଷ−supplementation produced small improvements in performance for all tests but 298 
the effects were not statistically significant (Table 2). Similarly, ܱܰଷ− supplementation had 299 
no significant effect on total energy physical activity or on each type of physical activity (i.e., 300 
sedentary, light, moderate, vigorous) (Table 3).   301 
4. DISCUSSION 302 
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4.1 Summary of Research Findings: This is the first study to evaluate the effects of dietary 303 ܱܰଷ−  supplementation on physical performance assessed in research settings and free-living 304 
conditions in healthy older participants. Contrary to the large body of evidence supporting a 305 
positive effect of dietary ܱܰଷ−  supplementation on exercise performance, our study showed 306 
no effects of ܱܰଷ−  supplementation on O2 consumption during sub-maximal and maximal 307 
exercise performance in older healthy participants. In addition, there were no significant 308 
effects of dietary ܱܰଷ−  supplementation on measures of physical capability and free-living 309 
physical activity.  310 
4.2 Comparison with Body of Evidence: Research into the effects of dietary ܱܰଷ−on exercise 311 
performance has been influenced by two significant events: 1) first paper published by Larsen 312 
et al in 2007[12] reporting a reduced sub-maximal O2 consumption after three-day oral ܱܰଷ− 313 
supplementation and 2) development of a ܱܰଷ−-depleted and ܱܰଷ−-enriched concentrated 314 
beetroot juice which has allowed the design of robust double-blind, randomized nutritional 315 
interventions[11]. Since 2007, several RCTs have tested the effects of dietary ܱܰଷ−on 316 
exercise performance in humans. A small number of these trials supplemented participants 317 
with pharmacological preparation (sodium or potassiumܱܰଷ−)[3, 12, 19, 21, 33-35] whereas 318 
the majority of the trials used beetroot juice as a way to increase dietary ܱܰଷ− intake[9-11, 16, 319 
23, 25, 36]. Most of the studies recruited mainly young, physically fit participants and only a 320 
few trials [9-11, 13, 15-17, 37, 38] have tested the effects of dietary ܱܰଷ−in older participants 321 
(mean age range: 63 – 70 years). The first study in older participants was conducted in eight 322 
patients with PAD who received 3.5 hours before the exercise testing either 500ml of 323 
beetroot juice or orange juice[10]. The study found an increased exercise time before onset of 324 
claudication pain and time to exhaustion. The remaining studies in older participants have 325 
reported contrasting results, which may be explained by differences in the duration of 326 
supplementation (range: 2.5 hours[15] to 14 days[11]), type of population (healthy[9, 13], 327 
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PAD[11], COPD[15, 16], type 2 diabetes[11], heart failure[14, 17]), dose of ܱܰଷ− (range: ~ 328 
300 – ~ 700mg) or exercise test (walking test[9, 10, 16, 25], incremental exercise[10, 14], 329 
forearm exercise[13]). Overall, the results have showed a reduced responsiveness of older 330 
participants to dietary ܱܰଷ−supplementation. Negative results were seen in healthy older 331 
participants[9] and patients with diabetes[25] and COPD[16], whereas improved exercise 332 
performance was observed in patients with heart failure[14] and PAD[10]. Our study 333 
confirmed that dietary ܱܰଷ−  supplementation for one week in older adults produced no 334 
beneficial effects on physical capability or exercise performance measured in standardized 335 
clinical settings. In addition, we reported for the first time a lack of effect of  ܱܰଷ−  336 
supplementation on free living physical activity, which may entail a re-examination of the 337 
usefulness of dietary ܱܰଷ−  supplementation as a viable nutritional population strategy to 338 
enhance physical performance. 339 
4.3 Biological Mechanisms: Dietary ܱܰଷ−is converted to NO in a two-step reduction process 340 
proceeding via the intermediate formation of ܱܰଶ−. The first step is performed by saprophytic 341 
bacteria with reductase activity colonizing the dorsal area of the tongue. ܱܰଶ− is then either 342 
converted to NO in the acidic gastric environment or transported in blood and reduced 343 
enzymatically in areas of tissues with lower oxygen tension and pH where metabolic 344 
demands are higher[39]. The latter conditions are frequently encountered in areas of 345 
contracting muscles, which favour the ܱܰଶ− conversion into NO to enhance coupling between 346 
muscle perfusion and metabolic activities[5]. The improved metabolic activity reported in 347 
previous studies appears to be related to an increased mitochondrial efficiency and/or 348 
reduction of the energetic cost of muscle contractions[6]. This raises important questions 349 
about why ܱܰଷ− supplementation does not improve physical capability or function in older 350 
people and stimulate future studies to investigate mechanisms that may explain the reduce 351 
effects of  ܱܰଷ−  supplementation on muscular performance with aging. Putative mechanisms 352 
15 
 
may involve altered reductase capacity to convert ܱܰଷ−  into NO or reduced effects of NO on 353 
skeletal muscle mediated by age-related changes in mitochondrial function and contractile 354 
efficiency. Whether higher doses or longer supplementation periods may overcome the 355 
alleged age-related decline in muscular response to dietary ܱܰଷ−  supplementation is currently 356 
not known.  357 
4.4 Limitations: The small sample size and the relatively short duration of the intervention 358 
are important limitations of this study and therefore the results may require a careful 359 
interpretation. While we measured plasma ܱܰଶ− concentrations using GCMS, due to logistic 360 
constraints it was not possible to process the samples immediately after collection to 361 
minimise ܱܰଶ− degradation. These results are therefore unavailable. However, previous 362 
studies involving dietary ܱܰଷ− supplementation in older participants where plasma 363 ܱܰଶ− concentration was measured, an increase in plasma ܱܰଷ− concentrations similar to the 364 
amount observed in this study occurred alongside a signiﬁcant rise in 365 
plasma ܱܰଶ− concentrations [40]. 366 
5. CONCLUSIONS 367 
We tested for the first time the ergogenic effects of dietary ܱܰଷ−supplementation in older 368 
participants on exercise performance and free-living physical activity and found that, overall, 369 
dietary ܱܰଷ−supplementation had no effects. The results seem to indicate that aging may 370 
modify the muscular response to dietary ܱܰଷ−supplementation. However, these results await 371 
confirmation in future studies with larger samples size and in targeted populations with 372 
impaired muscular performance.   373 
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FIGURE LEGENDS 525 
Figure 1: Description of recruitment phases 526 
Figure 2: Changes in plasma and urinary nitrate after either one-week supplementation of 527 
nitrate-rich or nitrate-depleted beetroot juice in 19 older healthy adults. Data presented as 528 
means±95%CI. A paired t test was applied to test differences between the two interventions 529 
at baseline and end of the study. 530 
Figure 3: Differences in gas exchanges and heart rate after one-week supplementation with 531 
either nitrate-rich or nitrate-depleted (placebo) beetroot juice in 19 older healthy adults. Data 532 
presented as means±95%CI.  A repeated-measure ANOVA model was applied to test 533 
differences between the two interventions at the end of each intervention.  V̇O2 = oxygen 534 
volume; V̇CO2 = carbon dioxide volume; RER= respiratory exchange ratio; V̇E= pulmonary 535 
ventilation; HR= heart rate.  536 
 537 
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Table 1: Baseline characteristics (N=19) 
  
 Means SD 
M/F 9/10 
Age (years) 64.7 3.0 
BMI (kg/m2) 25.6 3.4 
WC (cm) 88.5 13.9 
FM (kg) 22.0 6.3 
FFM( kg) 50.2 11.5 
Resting Systolic BP (mmHg) 127.4 16.1 
Resting Diastolic BP (mmHg)  76.2 9.6 
Energy Intake (Kcal/day) 2728 1431 
CHO (g/day) 308 152 
FAT (g/day) 107 73 
PRO (g/day) 103 57 
Saturated Fat (g/day) 35.6 26.5 
Unsaturated Fat (g/day) 14.1 10.4 
Fibre (g/day) 23.9 13.0 
N= number of participants; M= Male; F= Female; Body mass index= body mass index; WC= waist circumference; FM= fat 538 
mass; FFM= fat free mass; BP= blood pressure; CHO= carbohydrate; FAT= fat; PRO= protein; 539 
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 540 
      541 
Table 2: Measures of physical capability before and after supplementation with either nitrate-rich or nitrate-depleted 
(placebo) beetroot juice for one week. 
 Placebo  Nitrate   
 Baseline End Baseline End Main Effect 
Hand-Grip Strength (kg) 28.92±9.09 29.49±9.26 29.24±9.34 29.51±9.92 0.53 
Time Up and Go (seconds) 5.44±0.76 5.62±0.76 5.67±1.07 5.58±1.00 0.53 
Repeated Chair Standing (seconds) 8.03±2.24 7.65±1.73 7.73±1.77 7.60±1.73 0.41 
10m Walking Test (seconds) 2.83±0.60 2.80±0.44 2.94±0.53 2.84±0.54 0.79 
Data presented as means±SD. A repeated-measure ANOVA model was applied to test differences between the two interventions at the end 542 
of each intervention in 19 older healthy adults.   543 
 544 
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 545 
Table 3: Measures of free living physical activity after supplementation with either nitrate-rich or nitrate-depleted (placebo) beetroot juice measured over each one-week intervention with either placebo or nitrate. 
 Placebo Nitrate Δ P 
Total Physical Activity (kcal) 3378.66±1615.62 3066.11±1274.17 -312.55 ± 904.17 0.14 
Average Length of Sedentary Bouts (minutes) 170.15±41.57 175.73±68.76 5.57±68.73 0.72 
Daily Average of Sedentary Bouts (minutes) 184.10 ± 194.84 136.10 ± 155.60 -48.01 ± 85.25 0.40 
Average Length of Sedentary Breaks (minutes) 110.31±42.81 129.10±86.42 18.78±100.36 0.42 
Daily Average of Sedentary Breaks (minutes) 331.05 ± 102.62 322.68 ± 94.62 -8.38 ± 56.28 0.79 
Time in Sedentary Activity (minutes) 8993.68±984.47 8473.15±2139.85 -520.52±1782.42 0.21 
Time in Light Activity (minutes) 2690.31±1194.68 2520.63±1171.47 -169.68±806.39 0.37 
Time in Moderate Activity (minutes) 249.42±149.13 222.42±144.92 -26.94±97.83 0.24 
Time in Vigorous Activity (minutes) 32.94±94.86 20.52±56.40 -12.42±54.82 0.19 
Data presented as means±SD. Δ= difference between placebo and beetroot juice groups. A paired t test was used to compare differences between the two interventions for free living physical activity outcomes in 19 546 
older healthy adults.  547 
 548 
 549 
 550 
 551 
 552 
 553 
 554 
 555 
